With an educational background in chemistry, Matt concentrates his practice in intellectual property matters with a focus on patent prosecution and intellectual property diligence and transactions.
Before practicing law, Matt worked as a research specialist in a laboratory at the Emory University School of Medicine that focused on exploring molecular pathways through kidney protein expression. Matt’s educational background and research experience make him well-versed in the chemical and biological sciences.
Matt graduated, with honors, from the Emory University School of Law, where he served as an online editor on the Emory Law Journal. During law school, Matt worked as an extern in the global patents group of a Fortune 100 company, gaining valuable experience with freedom-to-operate opinions and foreign patent laws in the computer software and chemical arts. He also completed Georgia Tech’s TI:GER (Technological Innovation: Generating Economic Results) program, where he conducted intellectual property and commercialization research for medical device and wireless technology startups.
- Distributed ledger technology
- Artificial intelligence and machine learning
- Medical devices
- Data security and cryptography
- Raman spectroscopy
- Cell and molecular biology
- Industrial processes
- Authentication systems
- Database systems
- Cloud networking
- Co-Authored Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin, 301 Am. J. Physiology - Renal Physiology F1314, September 2011
- Co-Authored Pendrin modulates ENaC function by changing luminal HCO3-, 21 J. Am. Soc. Nephrology 1928, November 2010